BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9661634)

  • 21. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?
    Yamamoto M; Akatsu T; Nagase T; Ogata E
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4583-91. PubMed ID: 11134112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.
    Pollak MR; Brown EM; Estep HL; McLaine PN; Kifor O; Park J; Hebert SC; Seidman CE; Seidman JG
    Nat Genet; 1994 Nov; 8(3):303-7. PubMed ID: 7874174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activating mutations of the calcium-sensing receptor: management of hypocalcemia.
    Lienhardt A; Bai M; Lagarde JP; Rigaud M; Zhang Z; Jiang Y; Kottler ML; Brown EM; Garabédian M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5313-23. PubMed ID: 11701698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.
    Baron J; Winer KK; Yanovski JA; Cunningham AW; Laue L; Zimmerman D; Cutler GB
    Hum Mol Genet; 1996 May; 5(5):601-6. PubMed ID: 8733126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
    Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
    J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
    Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of pathogenic calcium sensing receptor mutations in sporadic idiopathic hypoparathyroidism.
    Sarin R; Tomar N; Ray D; Gupta N; Sharma YD; Goswami R
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):359-63. PubMed ID: 16918956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ca(2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism.
    Løvlie R; Eiken HG; Sørheim JI; Boman H
    Hum Genet; 1996 Aug; 98(2):129-33. PubMed ID: 8698326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
    Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
    J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger.
    Brown EM; Chattopadhyay N; Vassilev PM; Hebert SC
    Recent Prog Horm Res; 1998; 53():257-80; discussion 280-1. PubMed ID: 9769711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation.
    Cetani F; Pardi E; Borsari S; Tonacchera M; Morabito E; Pinchera A; Marcocci C; Dipollina G
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):199-206. PubMed ID: 12580936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene.
    Chikatsu N; Watanabe S; Takeuchi Y; Muraosa Y; Sasaki S; Oka Y; Fukumoto S; Fujita T
    Endocr J; 2003 Feb; 50(1):91-6. PubMed ID: 12733714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
    Piret SE; Gorvin CM; Pagnamenta AT; Howles SA; Cranston T; Rust N; Nesbit MA; Glaser B; Taylor JC; Buchs AE; Hannan FM; Thakker RV
    J Bone Miner Res; 2016 Jun; 31(6):1207-14. PubMed ID: 26818911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.
    Suzuki M; Aso T; Sato T; Michimata M; Kazama I; Saiki H; Hatano R; Ejima Y; Miyama N; Sato A; Matsubara M
    Clin Nephrol; 2005 Jun; 63(6):481-6. PubMed ID: 15960151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
    Maruca K; Brambilla I; Mingione A; Bassi L; Capelli S; Brasacchio C; Soldati L; Cisternino M; Mora S
    Mol Cell Endocrinol; 2017 Jan; 439():187-193. PubMed ID: 27561204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mutation in Ca2+-sensing receptor gene in familial hypocalciuric hypercalcemia.
    Nakayama T; Minato M; Nakagawa M; Soma M; Tobe H; Aoi N; Kosuge K; Sato M; Ozawa Y; Kanmatsuse K; Kokubun S
    Endocrine; 2001 Aug; 15(3):277-82. PubMed ID: 11762699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms.
    Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB
    J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.